These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22175029)

  • 1. Lipid nanocapsule-based gels for enhancement of transdermal delivery of ketorolac tromethamine.
    Varshosaz J; Hajhashemi V; Soltanzadeh S
    J Drug Deliv; 2011; 2011():571272. PubMed ID: 22175029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
    Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
    Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of ketorolac tromethamine permeability through rat skin using penetration enhancers: An ex-vivo study.
    Kumar P; Singh SK; Mishra DN; Girotra P
    Int J Pharm Investig; 2015; 5(3):142-6. PubMed ID: 26258055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
    Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
    J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
    Cho YA; Gwak HS
    Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of ketorolac.
    Amrish C; Kumar SP
    Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
    Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
    J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia.
    El-Tokhy FS; Abdel-Mottaleb MMA; Abdel Mageed SS; Mahmoud AMA; El-Ghany EA; Geneidi AS
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
    Li K; Gao S; Tian B; Shi Y; Lv Q; Han J
    Curr Drug Deliv; 2018; 15(3):424-435. PubMed ID: 29219057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of alternative strategies to optimize ketorolac transdermal delivery.
    Puglia C; Filosa R; Peduto A; de Caprariis P; Rizza L; Bonina F; Blasi P
    AAPS PharmSciTech; 2006 Aug; 7(3):64. PubMed ID: 17025245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery system of nanostructured lipid carriers loaded with Celastrol and Indomethacin: optimization, characterization and efficacy evaluation for rheumatoid arthritis.
    Kang Q; Liu J; Zhao Y; Liu X; Liu XY; Wang YJ; Mo NL; Wu Q
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S585-S597. PubMed ID: 30306802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil.
    Mendes IT; Ruela ALM; Carvalho FC; Freitas JTJ; Bonfilio R; Pereira GR
    Colloids Surf B Biointerfaces; 2019 May; 177():274-281. PubMed ID: 30763792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.